Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer using interleukin-12p40 variants having improved stability

Methods of treating cancer using interleukin-12p40 variants having improved stability

US Patent 9029330 · Granted May 12, 2015

Estimated economic value: $67,061,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted TGFβ inhibition2022
Anti-CD19 antibodies with reduced immunogenicity2021
SIRP-α immunoglobulin fusion proteins2021
Methods of use of anti-CD19 antibodies with reduced immunogenicity2018
Targeted TGFβ inhibitors2017
Anti-CD19 antibodies with reduced immunogenicity2015
Antibody fusion proteins with a modified FcRn binding site2014
Antibody fusion proteins with a modified FcRn binding site2014
Expression and export of angiogenesis inhibitors as immunofusins2014
Anti-CD19 antibodies with reduced immunogenicity2014
Engineered anti-alpha V-integrin hybrid antibodies2013
Stabilization of Fc-interferon-beta fusion proteins2013